Aquestive Therapeutics, Inc.
At Close: 4:00 PM
After Market: 9:09 PM
Aquestive Therapeutics, Inc.
AQST Stock Price Today
Aquestive Therapeutics, Inc. (AQST) stock declined over -3.37% intraday to trade at $0.86 a share on NASDAQ. The stock opened with a gain of 1.00% at $0.899 and touched an intraday high of $0.899, falling -3.37% against the last close of $0.89. The Aquestive Therapeutics, Inc. in stock market went to a low of $0.85 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue$49.9 Million
5Y Sales Change-0.40%
Fiscal Year EndsDec. 2021
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; Zuplenz, an oral soluble film formulation of ondansetron for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery; and Azstarys, a once-daily product for the treatment of attention deficit hyperactivity disorder. The company's proprietary product candidates comprise Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; and Exservan, an oral soluble film formulation of riluzole for the treatment of amyotrophic lateral sclerosis. Its proprietary pipeline of complex molecule products include AQST-108, a sublingual film formulation delivering systemic epinephrine for the treatment of conditions other than anaphylaxis; AQST-305, a sublingual film formulation of octreotide for the treatment of acromegaly; and AQST-109, an orally delivered epinephrine product candidate for the emergency treatment of allergic reactions, including anaphylaxis. Further, the company develops KYNMOBI, a sublingual film formulation of apomorphine for the treatment of episodic off-periods in Parkinson's disease. Aquestive Therapeutics, Inc. was incorporated in 2004 and is headquartered in Warren, New Jersey.
Frequently Asked Questions
What is the current Aquestive Therapeutics, Inc. (AQST) stock price?
Aquestive Therapeutics, Inc. (NASDAQ: AQST) stock price is $0.86 in the last trading session. During the trading session, AQST stock reached the peak price of $0.899 while $0.85 was the lowest point it dropped to. The percentage change in AQST stock occurred in the recent session was -3.37% while the dollar amount for the price change in AQST stock was -$0.03.
AQST's industry and sector of operation?
The NASDAQ listed AQST is part of Pharmaceuticals industry that operates in the broader Health Care sector. Aquestive Therapeutics, Inc. , a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally.
Who are the executives of AQST?
Ms. Theresa Wood
Sr. VP of HR
Dr. Gary H. Slatko M.D., MBA
Sr. VP & Chief Medical Officer
Mr. Daniel Barber
CEO, Pres & Director
Mr. A. Ernest Toth Jr.
Sr. VP & CFO
How AQST did perform over past 52-week?
AQST's closing price is 0.39% higher than its 52-week low of $0.618 where as its distance from 52-week high of $3.19 is -0.73%.
How many employees does AQST have?
Number of AQST employees currently stands at 157. AQST operates from 30 Technology Drive, Warren, NJ 07059, United States.
Link for AQST official website?
Official Website of AQST is: https://www.aquestive.com
How do I contact AQST?
How many shares of AQST are traded daily?
AQST stock volume for the day was 208,846 shares. The average number of AQST shares traded daily for last 3 months was 263.79 Thousands.
What is the market cap of AQST currently?
The market value of AQST currently stands at $46.73 Million with its latest stock price at $0.86 and 53.42 Million of its shares outstanding.